Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders

• Váldodahkkit: Yaoye Tao (Dahkki), Shengjun Xu (Dahkki), Jianguo Wang (Dahkki), Li Xu (Dahkki), Chenzhi Zhang (Dahkki), Kangchen Chen (Dahkki), Zhengxing Lian (Dahkki), Junbin Zhou (Dahkki), Haiyang Xie (Dahkki), Shusen Zheng (Dahkki), Xiao Xu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Lipid metabolic disorders have become a major global public health concern. Fatty liver and dyslipidemia are major manifestations of these disorders. Recently, MicroRNA-33 (miR-33), a post-transcriptional regulator of genes involved in cholesterol efflux and fatty acid oxidation, has been considered...